Pfizer eyes rapid COVID-19 vaccine roll-out in Latam after U.S. go-ahead

FILE PHOTO: Pfizer's logo is reflected in a drop on a syringe needle in this illustration taken November 9, 2020. REUTERS/Dado Ruvic/Illustration/File Photo

BUENOS AIRES (Reuters) - U.S. drugmaker Pfizer Inc is hoping to rapidly roll out its experimental COVID-19 vaccine around Latin America soon after it gets emergency authorization in the United States, a senior executive said, which could be as early as next month.

Alejandro Cané, the North America chief of scientific and medical affairs for Pfizer's vaccines division, told Reuters in an interview in Buenos Aires that Latin America and elsewhere in the world should have a "similar timeline" to the United States.